Ticker brief
ARDX ARDELYX INC
Consumer, Non-cyclical · Biotechnology
last close
$3.78
1 day
-0.8%
14 days
-6.9%
mkt cap
$1.3B
signals 14d
5
authors 14d
5
crowd 14d
+0.11
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 86% | IV/HV 1.26× (as of 2026-05-05) |
| Skew — 25Δ RR 30d | -0.077 | 25Δ call IV − put IV |
| OI alarm | quiet | last alarm 2026-05-04 (z=2.4) |
Sentiment — last 14 days
daily mean sentiment, 2026-10-02 → 2026-10-14 · now +0.35 (−1 bearish … +1 bullish)
Who spoke5
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @bullishchart | C | -1.21 | 1 | +0.00 |
| @OzmosiHealth | C | · | 1 | +0.35 |
| @PrismMarketView | C | · | 1 | +0.25 |
| @PrismDM | A | -2.76 | 1 | +0.15 |
| @OptionsFlowBoss | C | · | 1 | +0.35 |
Recent signals5of 5 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-14 | @OptionsFlowBoss | +0.35 | Reports unusual bullish options-volume multiples halfway through the session. | — | tweet ↗ |
| 2026-10-12 | @PrismDM | +0.15 | Observational IBSRELA data show median GI visits falling from 4.5 to 3.0 among 470 patients. | — | tweet ↗ |
| 2026-10-12 | @PrismMarketView | +0.25 | Reports observational data showing fewer healthcare visits after IBSRELA, while noting causal limitations. | — | tweet ↗ |
| 2026-10-12 | @OzmosiHealth | +0.35 | Real-world data show reduced healthcare utilization after IBSRELA initiation. | — | tweet ↗ |
| 2026-10-02 | @bullishchart | +0.00 | Frames reimbursement policy as the key uncertainty for clinic adoption. | — | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.